Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
RVP
|
Thomas J Shaw
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct | 34,506 Added 0.22% |
$32,435
$0.94 p/Share
|
Oct 27
2025 |
|
NEOG
|
Amy M Rocklin
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,085 Reduced 3.51% |
$12,906
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
Amy M Rocklin
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,474 Added 13.77% |
$58,644
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
David H. Naemura
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,261 Reduced 5.0% |
$26,375
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
David H. Naemura
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,504 Added 15.38% |
$95,969
$6.19 p/Share
|
Oct 27
2025 |
|
AFB
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,686 Reduced 0.0% |
$282,289
$10.99 p/Share
|
Oct 27
2025 |
|
NSC
|
Richard H Anderson
Director |
BUY
Open market or private purchase
|
Indirect | 2,600 Added 0.0% |
$732,836
$281.86 p/Share
|
Oct 27
2025 |
|
NEOG
|
Douglas Edward Jones
Former COO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,481 Reduced 3.34% |
$21,547
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
Douglas Edward Jones
Former COO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,504 Added 12.93% |
$95,969
$6.19 p/Share
|
Oct 27
2025 |
|
NQP
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 37,169 Reduced 0.0% |
$447,143
$12.03 p/Share
|
Oct 27
2025 |
|
NEOG
|
John Edward Adent
Former CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,527 Reduced 2.29% |
$52,782
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
John Edward Adent
Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 38,759 Added 9.44% |
$239,918
$6.19 p/Share
|
Oct 27
2025 |
|
VICR
|
Robert Gendron
Corp. VP - Marketing |
SELL
Open market or private sale
|
Direct | 1,321 Reduced 19.73% |
$121,532
$92.0 p/Share
|
Oct 27
2025 |
|
VICR
|
Robert Gendron
Corp. VP - Marketing |
BUY
Exercise of conversion of derivative security
|
Direct | 1,321 Added 16.48% |
$91,201
$69.04 p/Share
|
Oct 27
2025 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 949 Reduced 100.0% |
$4,925
$5.19 p/Share
|
Oct 27
2025 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 949 Added 50.0% |
$56
$0.06 p/Share
|
Oct 27
2025 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 28,500 Added 0.0% |
$1,256,280
$44.08 p/Share
|
Oct 27
2025 |
|
NEOG
|
William T Boehm
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,553 Added 6.9% |
$21,566
$6.07 p/Share
|
Oct 27
2025 |
|
ECAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,802 Reduced 0.0% |
$426,507
$16.53 p/Share
|
Oct 27
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$1,996
$2.58 p/Share
|
Oct 27
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.3% |
$928
$2.58 p/Share
|
Oct 27
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$933
$933.51 p/Share
|
Oct 27
2025 |
|
NWFL
|
James Shook |
BUY
Open market or private purchase
|
Direct | 3,800 Added 44.03% |
$101,308
$26.66 p/Share
|
Oct 27
2025 |
|
BDX
|
Michael Feld
EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct | 57 Reduced 0.69% |
$10,602
$186.01 p/Share
|
Oct 27
2025 |
|
LRCX
|
Ava Harter
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,010 Added 8.73% |
$463,010
$77.04 p/Share
|
Oct 27
2025 |
|
LRCX
|
Ava Harter
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 9,010 Reduced 13.69% |
$1,418,804
$157.47 p/Share
|
Oct 27
2025 |
|
MPB
|
John E Noone
Director |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$59,020
$29.51 p/Share
|
Oct 27
2025 |
|
HURN
|
James Ronald Dail
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 578 Reduced 1.46% |
$89,590
$155.0 p/Share
|
Oct 27
2025 |
|
LAFAU
|
Christophe Charlier
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 244,286 Added 0.0% |
-
|
Oct 27
2025 |
|
LAFAU
|
La Fayette Sponsor LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 244,286 Added 8.01% |
-
|
Oct 27
2025 |
|
NEOG
|
Jeffrey D Capello
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,025 Added 6.18% |
$12,534
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
James C Borel
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,025 Added 2.1% |
$12,534
$6.19 p/Share
|
Oct 27
2025 |
|
EYES
|
Gregg Williams
Director |
BUY
Open market or private purchase
|
Indirect | 3,703,703 Added 0.0% |
$5,999,998
$1.62 p/Share
|
Oct 27
2025 |
|
QRHC
|
Barry M Kitt
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 62,867 Added 0.0% |
$85,499
$1.36 p/Share
|
Oct 27
2025 |
|
DK
|
Ezra Uzi Yemin
Director |
SELL
Open market or private sale
|
Indirect | 688 Reduced 0.0% |
$26,150
$38.01 p/Share
|
Oct 27
2025 |
|
DK
|
Ezra Uzi Yemin
Director |
SELL
Open market or private sale
|
Direct | 188 Reduced 0.11% |
$7,145
$38.01 p/Share
|
Oct 27
2025 |
|
VOR
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect | 90,941 Reduced 0.0% |
$2,557,260
$28.12 p/Share
|
Oct 27
2025 |
|
RONI-WT
|
8 Rivers Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 0.0% |
$754,000
$3.77 p/Share
|
Oct 27
2025 |
|
RONI-WT
|
Npeh, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 6.74% |
$754,000
$3.77 p/Share
|
Oct 27
2025 |
|
CNTA
|
Mario Alberto Accardi
President, Orexin Program |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 3.95% |
$200,000
$25.0 p/Share
|
Oct 27
2025 |
|
CNTA
|
Mario Alberto Accardi
President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 2.41% |
$40,050
$8.01 p/Share
|
Oct 27
2025 |
|
AEHR
|
Donald P. Richmond Ii
CTO |
SELL
Payment of exercise price or tax liability
|
Direct | 102 Reduced 0.05% |
$2,564
$25.14 p/Share
|
Oct 27
2025 |
|
AEHR
|
Alistair N Sporck
VP Contactor Business Unit |
SELL
Payment of exercise price or tax liability
|
Direct | 132 Reduced 0.45% |
$3,318
$25.14 p/Share
|
Oct 27
2025 |
|
AEHR
|
Gayn Erickson
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 819 Reduced 0.31% |
$20,589
$25.14 p/Share
|
Oct 27
2025 |
|
AEHR
|
Adil Engineer
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 142 Reduced 0.3% |
$3,569
$25.14 p/Share
|
Oct 27
2025 |
|
AEHR
|
Vernon Rogers
Exec VP of Sales & Mktg. |
SELL
Payment of exercise price or tax liability
|
Direct | 197 Reduced 0.11% |
$4,952
$25.14 p/Share
|
Oct 27
2025 |
|
MTSI
|
Susan Ocampo
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 60,705 Reduced 0.0% |
$8,924,849
$147.02 p/Share
|
Oct 27
2025 |
|
CYTK
|
Wendell Wierenga
Director |
SELL
Open market or private sale
|
Direct | 4,375 Reduced 11.88% |
$256,725
$58.68 p/Share
|
Oct 27
2025 |
|
CYTK
|
Wendell Wierenga
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,375 Added 10.62% |
$43,750
$10.0 p/Share
|
Oct 27
2025 |
|
WDFC
|
Daniel T Carter |
BUY
Open market or private purchase
|
Direct | 1,000 Added 12.19% |
$199,370
$199.37 p/Share
|
Oct 27
2025 |